	Target trial emulation of survival outcomes for clinically localized prostate cancer treatments. Discov Oncol An MH, Kim C, Min K, Yi KH, Park RW, Jung M. PMID: 42286375 [PubMed - as supplied by publisher]
	Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials. Prostate Cancer Prostatic Dis Zhao J, Cai X, Mo Z, Zhao D, Wang J, Yang Z, Long X, Li Y, Chen D, Li J, Zhou Z, Li S, Li Y. PMID: 42286315 [PubMed - as supplied by publisher]
	Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer. Clin Genitourin Cancer Morgan TM, Lenz LH, Henriquez I, Monda SM, García-Pablo R, Clegg W, Finch R, Mabey B, Britton C, Crawford ED, Lewicki P, Punnen S, Shore ND, Tosoian JJ, Jasper J, Gutin A, Schiewer MJ, Tward JD. PMID: 42285797 [PubMed - as supplied by publisher]
	XpertÂ® bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial. Clin Chim Acta Trabelssi M, Lamy PJ, Daures JP, Perriard F, Poinas G. PMID: 42285342 [PubMed - as supplied by publisher]
	Application Value of Radiomics-Based Machine Learning for Preoperative Risk Stratification of Bladder Cancer: Systematic Review and Meta-Analysis. J Med Internet Res He Z, Liu Y, Jiang Q, Hou F, Xu B. PMID: 42285048 [PubMed - in process]
	Citalopram enhances cisplatin-induced cytotoxicity in T24 bladder cancer cells: An in vitro study. Exp Mol Pathol Ahmadi P, Deyhimfar R, Haghani I, Mohammadi A, Guitynavard F, Khatami F, Menbari Oskouie I, Reis LO, Aghamir SMK. PMID: 42284726 [PubMed - as supplied by publisher]
	Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus. ESMO Open Aragon-Ching JB, Gupta S, Grivas P, Park SH, Petrylak DP, Sridhar SS, Gurney H, Jacob N, Tyroller K, Hoffman J, Bellmunt J. PMID: 42284622 [PubMed - as supplied by publisher]
	Phenotyping Prostate Cancer in a National Health System Using Large Language Models. JCO Clin Cancer Inform Dykstra MP, Tsao PA, Caram MEV, Nieto J, Schipper M, Stensland KD, Elliott D, Rose BS, Bryant AK. PMID: 42284546 [PubMed - indexed for MEDLINE]
	Precision Nodal Staging in Intermediate-Risk Prostate Cancer: A Narrative Review of Molecular Imaging. Urol Int Shen B, Wang F. PMID: 42284273 [PubMed - as supplied by publisher]
	High-Intensity Focused Ultrasound Versus Robot-Assisted Radical Prostatectomy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Oncologic and Functional Outcomes. Ann Surg Oncol Ge S, Zeng Z, Zheng L. PMID: 42283919 [PubMed - as supplied by publisher]
	Metabolic vulnerabilities in advanced prostate cancer: the interplay of ferroptosis, cuproptosis, and the inflammatory microenvironment. Med Oncol Motafeghi F, Mortazavi P, Hossein Hosseinzadeh M, Ghassemi Barghi N. PMID: 42283905 [PubMed - indexed for MEDLINE]
	Multicenter Study Suggests Unsupervised Learning Derived From MRI Identifies Prognostic Subgroups in Prostate Cancer Patients After Prostatectomy. Radiol Res Pract Hu G, Liu X, Chen Z, Zhou B, Gan H, Chen R, Zhou L, Gu Y, Liu X. PMID: 42283020 [PubMed]
	Antibiotic stewardship and safety in office-based transrectal prostate biopsy: a single-center retrospective analysis of complications. J Med Life Salloum O, Cergan R, Sanda NA, Dick A, Petcu C, Gingu C, Buturin AN, Costache A. PMID: 42282230 [PubMed - indexed for MEDLINE]
	Extracellular vesicles in prostate cancer: current understanding and future perspectives. J Natl Cancer Cent Perumalsamy B, Seshacharyulu P, Vengoji R, Shonka N, Teply BA, Batra SK, Muniyan S. PMID: 42282127 [PubMed]
	Construction and external validation of radiomics models to detect primary prostate cancer with machine learning: a multicenter study based on (68)Ga-PSMA PET/CT. J Natl Cancer Cent Chen J, Jiang X, Yang G, Tang Y, Qi L, Chen M, Hu S, Gao X, Gan Y, Zhang M, Chen S, Cai Y. PMID: 42282124 [PubMed]
	Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study. Res Rep Urol Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42281847 [PubMed]
	Natural Flavonoids Genistein and Baicalein as Well-Tolerated Radiosensitizers to Enhance the Efficacy of (177)Lu-PSMA617 in Prostate Cancer: InÂ Vitro and InÂ Vivo Studies. Research (Wash D C) He C, Shao Y, Bao Y, Li J, Si H, He J. PMID: 42281770 [PubMed]
	Epidemiological Trends and Burden of Adult Kidney Cancer in Saudi Arabia: A 42-Year Retrospective Analysis (1982-2023). Cancer Rep (Hoboken) Flemban AF, Kabrah SM, Alahmadi H, Alahdali LS, Maksood LS, Alqurashi MA, Kutbi OJ, Abd Elmoneim HM, Bakhsh A, Almouhissen T, Ekram SN, Albar HT, Tayeb W. PMID: 42281475 [PubMed - indexed for MEDLINE]
	Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study. Nutrients Rolley C, Zidane M, Nedelcu C, Barth M, Saulnier P, Procaccio V, Bigot P. PMID: 42280354 [PubMed - indexed for MEDLINE]
	Automated H-Scoring in Muscle-Invasive Bladder Cancer IHC: An Internal Validation Study. Diagnostics (Basel) Yap M, Mihai IM, Alanazi MAA, Olteanu GE, Contreras-Sanz A, Black P, Wang G. PMID: 42279541 [PubMed]

Articles 1 - 20 / 178947

Page 1 of 8948



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy